Activating Ras mutations are involved in a significant fraction of human tumors. A suppressor screen using a retroviral mouse fibroblast cDNA library was performed to identify novel factors in Ras-mediated transformation. We identified a novel potent inhibitor of Ras-mediated morphological transformation encoded by a truncated version of the receptor for activated C-kinase (RACK1). The truncated protein, designated RACK1DWD1, lacked the N-terminal 49 amino acids encoding the first of the 7 WD40 repeats in RACK1. RACK1DWD1 expression restored contact inhibition, stress fiber formation and reduced ERK phosphorylation in Ki-Ras transformed NIH 3T3 cells. We demonstrate that truncated RACK1 is involved in complexes consisting of wildtype RACK1 and protein kinase C isoforms a, bI and d, compromising the transduction of an activated Ras signal to the Raf-MEK-ERK pathway. The cellular localization of RACK1DWD1 differed from wtRACK1, indicating that signaling complexes containing the truncated version of RACK1 are incorrectly localized. Notably, 12-O-tetradecanoyl-13-phorbol acetate (TPA) mediated intracellular translocation of RACK1-interacting PKC a and d was abrogated in RACK1DWD1-expressing cells. Our data support a model where RACK1 acts as a key factor in Ki-Ras-mediated morphological transformation. ' 2006 Wiley-Liss, Inc.Key words: ERK; PKC; RACK1; Ras; transformation Members of the ras gene family (Ki-ras, Ha-ras and N-ras) are structurally related and encode proteins (p21) known to play an important role in the regulation of normal signal transduction and cell growth. A range of ras mutations are present with high frequency in different human tumors. The mechanism by which mutated Ras contributes to cancer development and morphological transformation of cells is still not completely understood. Ras generates downstream effects through Raf, Rac and Rho affecting cell growth, lamellipodia formation and stress fiber formation, respectively.1-3 Activated Ras recruits Raf-1 from the cytosol to the cell membrane, where Raf-1 activation takes place through dephosphorylation of inhibitory sites by protein phosphatase 2A (PP2A) as well as the phosphorylation of activating sites by a range of kinases. Activated Raf-1 phosphorylates and activates MEK (ERK/ MAPK kinase), which in turn phosphorylates and activates extracellular-signal-regulated kinase (ERK/MAPK). Activated ERK has many substrates in the cytosol, and in the nucleus it controls gene expression by phosphorylating transcription factors such as Elk-1 and other Ets-family proteins. [4][5][6] The activation of the ERK/ MAPK pathway is central in Ras signaling, and expression of active ERK is sufficient to transform 3T3 cells.7 Importantly, mutations in B-Raf are frequently observed in human cancers (melanomas). In addition, the c-Jun N-terminal kinase (JNK)/ MAPK pathway, 22 In an attempt to identify and characterize novel factors inhibiting the transforming signal of mutated Ki-Ras, we used a retroviral cDNA expression screen in NIH 3T3 cells. Here, we show th...